CYDY
What one share of Cytodyn holds
Pharmaceutical Preparations
CytoDyn Inc. (together with its wholly owned subsidiary, the “Company”) was originally incorporated under the laws of Colorado on May 2, 2002, under the name RexRay Corporation and, effective August 27, 2015, reincorporated under the laws of Delaware.
Cytodyn’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-08-31; the balance sheet is as of 2026-08-31.
| Profit | −$0.04 |
|---|---|
| Cash and investments | $0.01 |
| Debt | $0.02 |
| Book value | −$0.07 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$0.19 | $0.00 | −$0.19 | — | −$0.01 |
| 2018 | — | −$0.29 | $0.00 | −$0.17 | — | −$0.06 |
| 2019 | — | −$0.22 | $0.00 | −$0.19 | — | −$0.03 |
| 2020 | — | −$0.33 | $0.00 | −$0.16 | — | −$0.00 |
| 2021 | $0.00 | −$0.30 | $0.00 | −$0.20 | — | −$0.03 |
| 2022 | $0.00 | −$0.31 | — | −$0.11 | — | −$0.13 |
| 2023 | $0.00 | −$0.10 | — | −$0.03 | — | −$0.12 |
| 2024 | — | −$0.05 | — | −$0.01 | — | −$0.11 |
| 2025 | — | $0.00 | — | −$0.01 | — | −$0.08 |
| 2026 | — | −$0.03 | — | −$0.01 | — | −$0.08 |